PL-20 CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer

Thrombosis Research

Volumn 129, Issue SUPPL. 1, 2012, Pages

  Sandset, Per Morten ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Chemokine; CXCL4; Heparin; Heparin induced thrombocytopenia; Thrombocytopenia; Thrombosis

Indexed keywords

CXCL4 PLATELET FACTOR 4; HEPARIN; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG;

ANGIOGENESIS; ATHEROSCLEROSIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMOTAXIS; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; EMBRYO DEVELOPMENT; GRANULOCYTE; HEMATOPOIESIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOBIOLOGY; LEUKOCYTE MIGRATION; METASTASIS; MONOCYTE; NATURAL KILLER CELL; NEOPLASM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; SCORING SYSTEM; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; TUMOR GROWTH; VEIN THROMBOSIS; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; REVIEW; THROMBOCYTOPENIA; THROMBOSIS;

HEPARIN; HUMANS; NEOPLASMS; PLATELET FACTOR 4; THROMBOCYTOPENIA; THROMBOSIS;

EID: 84862136361     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(12)70026-9     Document Type: Conference Paper

References (51)

1. E Deutsch, SA Johnson, WH Seegers Differentiation of certain platelet factors related to blood coagulation Circ Res 3 1955 110 115
2. A Zlotnik, O Yoshie Chemokines: a new classification system and their role in immunity Immunity 12 2000 121 127 (Pubitemid 30398626)
3. O Bruserud, AO Kittang The chemokine system in experimental and clinical hematology Curr Top Microbiol Immunol 341 2010 3 12
4. RM Strieter, PJ Polverini, SL Kunkel, DA Arenberg, MD Burdick, J Kasper et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis J Biol Chem 270 1995 27348 27357
5. MB Zucker, IR Katz Platelet factor 4: production, structure, and physiologic and immunologic action Proc Soc Exp Biol Med 198 1991 693 702
6. MA Kowalska, L Rauova, M Poncz Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis Thromb Res 2009
7. J Vandercappellen, DJ Van, S Struyf The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer Cytokine Growth Factor Rev 22 2011 1 18
8. S Struyf, L Salogni, MD Burdick, J Vandercappellen, M Gouwy, S Noppen et al. Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3 Blood 117 2011 480 488
9. AZ Dudek, CA Pennell, TD Decker, TA Young, NS Key, A Slungaard Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C J Biol Chem 272 1997 31785 31792 (Pubitemid 28013329)
10. GM Arepally, TL Ortel Clinical practice. Heparin-induced thrombocytopenia N Engl J Med 355 2006 809 817
11. TE Warkentin Drug-induced immune-mediated thrombocytopenia - from purpura to thrombosis N Engl J Med 356 2007 891 893 (Pubitemid 46339907)
12. A Greinacher Heparin-induced thrombocytopenia J Thromb Haemost 7 Suppl 1 2009 9 12
13. PM Sandset Immunobiology of heparin-induced thrombocytopenia Curr Top Microbiol Immunol 341 2010 193 202
14. J Amiral, F Bridey, M Dreyfus, AM Vissoc, E Fressinaud, M Wolf et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia Thromb Haemost 68 1992 95 96
15. A Greinacher, S Alban, MA Omer-Adam, W Weitschies, TE Warkentin Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings Thromb Res 122 2008 211 220
16. L Rauova, L Zhai, MA Kowalska, GM Arepally, DB Cines, M Poncz Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications Blood 107 2006 2346 2353 (Pubitemid 43345554)
17. JG Kelton, D Sheridan, A Santos, J Smith, K Steeves, C Smith et al. Heparin-induced thrombocytopenia: laboratory studies Blood 72 1988 925 930
18. C Pouplard, S Iochmann, B Renard, O Herault, P Colombat, J Amiral et al. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia Blood 97 2001 3300 3302
19. TE Warkentin, JG Kelton Temporal aspects of heparin-induced thrombocytopenia N Engl J Med 344 2001 1286 1292 (Pubitemid 32372963)
20. N Lubenow, R Kempf, A Eichner, P Eichler, LE Carlsson, A Greinacher Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin Chest 122 2002 37 42 (Pubitemid 34754140)
21. A Greinacher, T Kohlmann, U Strobel, JA Sheppard, TE Warkentin The temporal profile of the anti-PF4/heparin immune response Blood 113 2009 4970 4976
22. TE Warkentin, JA Sheppard, JC Moore, RJ Cook, JG Kelton Studies of the immune response in heparin-induced thrombocytopenia Blood 113 2009 4963 4969
23. K Selleng, TE Warkentin, JA Sheppard, A Greinacher Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies Transfusion 49 2009 1812 1818
24. TE Warkentin, A Greinacher, A Koster, AM Lincoff Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 2008 340S 380S (Pubitemid 351892970)
25. B Potzsch, WP Klovekorn, K Madlener Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia N Engl J Med 343 2000 515 (Pubitemid 30646499)
26. TE Warkentin, MN Levine, J Hirsh, P Horsewood, RS Roberts, M Gent et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
27. C Pouplard, MA May, S Iochmann, J Amiral, AM Vissac, M Marchand et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia Circulation 99 1999 2530 2536 (Pubitemid 29228283)
28. S Schenk, A El-Banayosy, M Morshuis, L Arusoglu, P Eichler, N Lubenow et al. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support J Thromb Haemost 5 2007 235 241 (Pubitemid 46139443)
29. TE Warkentin, JA Sheppard, P Horsewood, PJ Simpson, JC Moore, JG Kelton Impact of the patient population on the risk for heparin-induced thrombocytopenia Blood 96 2000 1703 1708 (Pubitemid 30661052)
30. GB Oliveira, EM Crespo, RC Becker, EF Honeycutt, CS Abrams, KJ Anstrom et al. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy Arch Intern Med 168 2008 94 102
31. M Ban-Hoefen, C Francis Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital Thromb Res 124 2009 189 192
32. A Greinacher, B Farner, H Kroll, T Kohlmann, TE Warkentin, P Eichler Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients Thromb Haemost 94 2005 132 135 (Pubitemid 40974717)
33. B Girolami, P Prandoni, PM Stefani, C Tanduo, P Sabbion, P Eichler et al. The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study Blood 101 2003 2955 2959 (Pubitemid 36857979)
34. P Prandoni, S Siragusa, B Girolami, F Fabris The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study Blood 106 2005 3049 3054 (Pubitemid 41565898)
35. P Prandoni, A Falanga, A Piccioli Cancer, thrombosis and heparin-induced thrombocytopenia Thromb Res 120 Suppl 2 2007 S137 S140
36. BJ Miriovsky, TL Ortel Heparin-induced thrombocytopenia in cancer J Natl Compr Canc Netw 9 2011 781 787
37. LA Linkins, AL Dans, LK Moores, R Bona, B Davidson, S Schulman et al. Treatment and Prevention of Heparin-Induced Thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e495S e530S
38. TE Warkentin, RS Roberts, J Hirsh, JG Kelton An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients Arch Intern Med 163 2003 2518 2524 (Pubitemid 37385796)
39. DE Wallis, DL Workman, BE Lewis, L Steen, R Pifarre, JF Moran Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia Am J Med 106 1999 629 635 (Pubitemid 29279299)
40. TE Warkentin Clinical picture of heparin-induced thrombocytopenia TE Warkentin A Greinacher Heparin-Induced Thrombocytopenia 4th ed. 2007 Informa Healthcare New York 21l66
41. TE Warkentin, JG Kelton Delayed-onset heparin-induced thrombocytopenia and thrombosis Ann Intern Med 135 2001 502 506 (Pubitemid 32923567)
42. TE Warkentin, NM Heddle Laboratory diagnosis of immune heparin-induced thrombocytopenia Curr Hematol Rep 2 2003 148 157
43. A Cuker, G Arepally, MA Crowther, L Rice, F Datko, K Hook et al. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion J Thromb Haemost 8 2010 2642 2650
44. MB Streiff, PL Bockenstedt, SR Cataland, C Chesney, C Eby, J Fanikos et al. Venous thromboembolic disease J Natl Compr Canc Netw 9 2011 714 777
45. GK Lo, D Juhl, TE Warkentin, CS Sigouin, P Eichler, A Greinacher Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings J Thromb Haemost 4 2006 759 765
46. C Pouplard, P Gueret, M Fouassier, C Ternisien, M Trossaert, S Regina et al. Prospective evaluation of the "4Ts" score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia J Thromb Haemost 5 2007 1373 1379 (Pubitemid 46965362)
47. AR Patrick, WC Winkelmayer, J Avorn, MA Fischer Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis Pharmacoeconomics 25 2007 949 961 (Pubitemid 350014528)
48. A Greinacher, D Juhl, U Strobel, A Wessel, N Lubenow, K Selleng et al. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes J Thromb Haemost 5 2007 1666 1673 (Pubitemid 47091409)
49. TE Warkentin, JA Sheppard, JC Moore, KM Moore, CS Sigouin, JG Kelton Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med 146 2005 341 346 (Pubitemid 41712020)
50. D Sheridan, C Carter, JG Kelton A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27 30 (Pubitemid 16167006)
51. A Greinacher, I Michels, V Kiefel, C Mueller-Eckhardt A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia Thromb Haemost 66 1991 734 736